Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2018

GlobalData's clinical trial report, “Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2018" provides an overview of Severe Acute Respiratory Syndrome (SARS) clinical trials scenario. This report provides top line data relating to the clinical trials on Severe Acute Respiratory Syndrome (SARS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Syri Ltd

Sinovac Biotech Ltd

Kineta Inc

Hemispherx Biopharma Inc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in North America 10

Clinical Trials by G7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials 11

Clinical Trials in G7 Countries by Trial Status 13

Clinical Trials by E7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials 14

Clinical Trials in E7 Countries by Trial Status 16

Clinical Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Clinical Trials by Sponsor Type 20

Prominent Sponsors 21

Top Companies Participating in Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials 22

Clinical Trial Profile Snapshots 23

Appendix 29

Abbreviations 29

Definitions 29

Research Methodology 30

Secondary Research 30

About GlobalData 31

Contact Us 31

Source 32

List of Tables

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Region, 2018* 7

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, North America, Top Countries, 2018* 10

Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 11

Severe Acute Respiratory Syndrome (SARS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 13

Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 14

Severe Acute Respiratory Syndrome (SARS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 16

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Phase, 2018* 17

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19

Severe Acute Respiratory Syndrome (SARS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 20

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 21

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 22

List of Figures

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9

Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 11

Severe Acute Respiratory Syndrome (SARS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 13

Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 14

Severe Acute Respiratory Syndrome (SARS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 16

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 17

Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18

Severe Acute Respiratory Syndrome (SARS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 20

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 21

Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 22

GlobalData Methodology 30

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports